摘要
2016年3月国务院发布《关于开展仿制药质量和疗效一致性评价的意见的公告》,国家食品药品监督管理总局(CFDA)陆续出台政策指导推动一致性评价工作加快开展。北京市为推动相关政策有效落实,科技部门和监管部门形成合力,出台了一系列政策措施,并设立专项资金,从加快重要品种开展一致性评价工作、建设关键技术平台等方面入手,抓住机遇推动北京生物医药产业创新发展。北京市的相关做法值得借鉴。
In March 2016, the State Department issued a notice on "Consistency evaluation of generic drug quality and efficacy". Then the China Food and Drug Administration (CFDA) has implemented a series of measures. Based on the situation, Beijing city government has organized the science and technology department and the supervision departments together, and established a special government fund to speed up enterprises promote related works and construct key technology platforms. Beijing government’s practices are worth learning.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2017年第12期1807-1817,共11页
Chinese Journal of Pharmaceuticals
关键词
仿制药一致性评价
科技创新
医药产业
政策
quality consistency evaluation of generic drugs
technological innovation
pharmaceutical industry
policy